Search
for
Sort by
Research 601–630 of 1000+
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata
- Pregnancy in postpartum estrus induces inflammatory milk production and catagen specific pup skin inflammation in interleukin-10 deficient mice
- Low Free Thyroxine (FT4) in critically ill juvenile systemic lupus erythematosus: a diagnostic approach
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Effects of local and systemic medications on eye health: Adverse reactions
- Clinical evaluation and treatment response in Patients with non-scarring alopecia: A Prospective Study of 200 Cases
- Cutaneous manifestations of systemic infection in children
- Cutaneous manifestations of systemic lupus erythematosus
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Case report: Systemic granulomatous disease with vasculitis in a bull due to hairy vetch (Vicia villosa) toxicosis
- DERMOSCOPIC EVALUATION OF THERAPEUTIC RESPONSE IN ALOPECIA AREATA
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Effects of olive leaf extract supplementation on systemic markers of tissue aging and remodeling in postmenopausal women: a randomized controlled trial with exploratory skin outcomes
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Red Light Revolution: Harnessing Photobiomodulation for Peak Athletic Performance and Systemic Healing
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Effect of mesenchymal stem cells on reducing melanin levels in response to UV radiation in male C57BL/6 mice
- 860 Understanding cellular & molecular responses in the treatment of pediatric lymphatic anomalies
- Distinct mechanisms for sebaceous gland self-renewal and regeneration provide durability in response to injury
- Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Clinical Patterns of Cutaneous and Mucosal Lesions in Patients with Systemic Lupus Erythematosus
- INVESTIGATION OF THE EFFECTS OF VISCERAL MASSAGE ON THE MORPHOFUNCTIONAL STATE OF THE SKIN AND SYSTEMIC METABOLISM